Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen C Nelson

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Cancer Research|October 19, 2011
Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progressionQian Wang, Charles G Bailey, Cynthia Ng, et al.
The Prostate|October 1, 2009
Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistanceJennifer A Locke, Emma S Tomlinson Guns, Melanie L Lehman, et al.
BMC Genomics|December 3, 2015
Fusion transcript loci share many genomic features with non-fusion lociJohn Lai, Jiyuan An, Inge Seim, et al.
Scientific Reports|December 6, 2017
A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressivenessJohn Lai, Leire Moya, Jiyuan An, et al.
Endocrine-Related Cancer|January 16, 2013
IGF2 increases de novo steroidogenesis in prostate cancer cellsAmy A Lubik, Jennifer H Gunter, Brett G Hollier, et al.
Oncotarget|October 4, 2014
Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancerNicole M A White-Al Habeeb, Linh T Ho, Ekaterina Olkhov-Mitsel, et al.
Plos One|November 21, 2018
No effect of unacylated ghrelin administration on subcutaneous PC3 xenograft growth or metabolic parameters in a Rag1-/- mouse model of metabolic dysfunctionMichelle L Maugham, Inge Seim, Patrick B Thomas, et al.
International Journal of Cancer|January 26, 2012
A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human diseaseVanessa C Thompson, Tanya K Day, Tina Bianco-Miotto, et al.
Molecular and Cellular Endocrinology|October 27, 2015
Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancerGregor Tevz, Sean McGrath, Ryan Demeter, et al.
Scientific Reports|March 30, 2017
Insights from engraftable immunodeficient mouse models of hyperinsulinaemiaMichelle L Maugham, Patrick B Thomas, Gabrielle J Crisp, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Cancer Research|October 19, 2011
Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progressionQian Wang, Charles G Bailey, Cynthia Ng, et al.
The Prostate|October 1, 2009
Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistanceJennifer A Locke, Emma S Tomlinson Guns, Melanie L Lehman, et al.
BMC Genomics|December 3, 2015
Fusion transcript loci share many genomic features with non-fusion lociJohn Lai, Jiyuan An, Inge Seim, et al.
Scientific Reports|December 6, 2017
A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressivenessJohn Lai, Leire Moya, Jiyuan An, et al.
Endocrine-Related Cancer|January 16, 2013
IGF2 increases de novo steroidogenesis in prostate cancer cellsAmy A Lubik, Jennifer H Gunter, Brett G Hollier, et al.
Oncotarget|October 4, 2014
Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancerNicole M A White-Al Habeeb, Linh T Ho, Ekaterina Olkhov-Mitsel, et al.
Plos One|November 21, 2018
No effect of unacylated ghrelin administration on subcutaneous PC3 xenograft growth or metabolic parameters in a Rag1-/- mouse model of metabolic dysfunctionMichelle L Maugham, Inge Seim, Patrick B Thomas, et al.
International Journal of Cancer|January 26, 2012
A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human diseaseVanessa C Thompson, Tanya K Day, Tina Bianco-Miotto, et al.
Molecular and Cellular Endocrinology|October 27, 2015
Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancerGregor Tevz, Sean McGrath, Ryan Demeter, et al.
Scientific Reports|March 30, 2017
Insights from engraftable immunodeficient mouse models of hyperinsulinaemiaMichelle L Maugham, Patrick B Thomas, Gabrielle J Crisp, et al.
Pageof 12